Journal
JOURNAL OF PHARMACEUTICAL ANALYSIS
Volume 11, Issue 4, Pages 458-464Publisher
ELSEVIER
DOI: 10.1016/j.jpha.2020.09.001
Keywords
CAMP; cGMP; Plasma; UHPLC-MS/MS; Yin-Yang disharmony
Categories
Funding
- National Natural Science Foundation of China [J1103606]
Ask authors/readers for more resources
A new method for determining cAMP and cGMP in rat plasma was developed in this study, taking into account their stability ex vivo, and was used to evaluate the regulatory effects of Chinese herbal medicine on the levels of cAMP and cGMP in the body.
Cyclic 3',5'-adenosine monophosphate (cAMP) and cyclic 3',5'-guanosine monophosphate (cGMP) are considered as potential biomarkers for Yin-Yang disharmony in traditional Chinese medicine. However, phosphodiesterase-mediated ex vivo degradation of these molecules in biological samples may result in their underestimation. In the present study, a ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was developed for determination of cAMP and cGMP in rat plasma, with special consideration of their stability ex vivo. Following precipitation of proteins from plasma samples with 0.4 M perchloric acid, the analytes were chromatographed on a Shimadzu Shim-pack-XR-ODS II column with 2.5 mM ammonium acetate and methanol in gradient mode. The MS/MS detection was performed using multiple reaction monitoring in the positive electrospray ionization mode. The lower limit of quantification was 0.27 ng/mL for cAMP and 0.37 ng/mL for cGMP. The method was used to determine the plasma cAMP and cGMP levels in normal and Yin deficiency diabetic rats treated with or without Rehmannia glutinosa. The developed method may be useful for evaluating the regulatory effects of Chinese herbal medicine on the levels of cAMP and cGMP in the body. (C) 2020 Xi'an Jiaotong University. Production and hosting by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available